AI assistant
Enovis CORP — Director's Dealing 2021
Nov 10, 2021
31808_dirs_2021-11-10_fd85c379-df80-4a94-b182-ad33362ca439.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Colfax CORP (CFX)
CIK: 0001420800
Period of Report: 2021-11-08
Reporting Person: Trerotola Matthew L. (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-08 | Common stock, par value $.001 | M | 50000 | $39.54 | Acquired | 355708 | Direct |
| 2021-11-08 | Common stock, par value $.001 | S | 49890 | $53.019 | Disposed | 305818 | Direct |
| 2021-11-08 | Common stock, par value $.001 | S | 110 | $53.815 | Disposed | 305708 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-08 | Employee Stock Option (right to buy) | $39.54 | M | 50000 | Disposed | 2022-07-23 | Common stock, par value $.001 (50000) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
F2: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.75 to $53.71, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
F3: The price reported in this row of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.76 to $53.82, inclusive. The reporting person undertakes to provide to Colfax Corporation, any security holder of Colfax Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4.
F4: The option vests in equal installments on the third, fourth and fifth anniversaries of the grant date, which was 7/24/2015.